Nanna Lüneborg, PhD, MBA, General Partner at Forbion, will participate in Life Sciences Update – Investments in Life Sciences, taking place on 31 August in Copenhagen.
Nanna will join the panel discussion “The Equity Story That Survives Due Diligence,” moderated by Jesper J. Lange and Caroline Boysen of Gorrissen Federspiel. The panel will explore what it takes to build a clear and credible equity story and how life sciences companies can ensure that their strategic and commercial narratives withstand investor scrutiny.
Hosted by Gorrissen Federspiel, the event will bring together investors, life sciences executives and industry experts to examine the strategic, commercial and financial considerations driving value creation across the sector. Discussions will address partnering and M&A opportunities, financing and valuation challenges, and the evolving regulatory landscape.
Speakers from Novo Holdings, EIFO, Sofinnova Partners, Antag Therapeutics, Mission Therapeutics and Novartis will also contribute perspectives on investment and transaction dynamics in today’s life sciences market.
The Life Sciences Update provides a focused forum for investors, companies and industry leaders to exchange perspectives on the investment landscape and connect with those shaping the future of life sciences.